Showing 1 to 1 of 1 results
mk.ru
🌐 75% Global Worthiness
Russia's Hematological Care: Funding Increases, But Access to Innovation Lags
In Russia, 1.22 million people have hematological diseases, 35% of whom have cancerous blood diseases; funding increased 1.5 times since 2019, yet access to innovative treatments lags behind Europe, with high costs for advanced therapies posing further challenges.
Russia's Hematological Care: Funding Increases, But Access to Innovation Lags
In Russia, 1.22 million people have hematological diseases, 35% of whom have cancerous blood diseases; funding increased 1.5 times since 2019, yet access to innovative treatments lags behind Europe, with high costs for advanced therapies posing further challenges.
Progress
28% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results